Atlas Trials

A Clinical Study Evaluating the Safety, Tolerability, and Effect on HIV Reservoir of Ibalizumab Combined With Chidamide (a Histone Deacetylase Inhibitor) in People Living With HIV

Clinical trial NCT07635992 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07635992
Sponsor
First Affiliated Hospital of Zhejiang University
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
HIV (Human Immunodeficiency Virus)
Start date
2026-06-01
Primary completion
2028-12-31
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.